HOME >> BIOLOGY >> NEWS
Alliance for Cancer Gene Therapy announces $1.5 million in national grants to young investigators

Margaret Cianci, Executive Director for the Alliance for Cancer Gene Therapy, Inc. (ACGT), a national foundation based in Stamford, Connecticut, announced today the award of national grants to three Young Investigators at major research institutions, totaling $1.5 million over three years, for separate cancer gene therapy research projects relating to neuroblastoma, prostate and ovarian cancers.

The recipients are Dr. Andrew Davidoff at St. Jude Children's Research Hospital, Memphis, Tennessee for the development of anti-angiogenic gene therapy for neuroblastoma, a deadly form of childhood cancer; Dr. Thomas Griffith at the University of Iowa for development and testing of an immunotherapy/vaccine therapy, Ad-5 TRAIL for future clinical trials in patients with prostate cancer; and Dr. Jeffrey Bartlett, at Children's Research Institute in Columbus, Ohio, for tumor targeting/vector development, creating a specific gene therapy delivery vehicle for patients with ovarian cancer.

Gene therapy is a revolutionary new form of treatment. It has emerged in recent years with the remarkable potential not only to deliver a cure for many types of cancers, but also to improve the quality of life with reduced side effects for patients undergoing treatments.

Every year, over a half million people die from cancer and another million are diagnosed with some form of the disease. Conventional therapies, including chemotherapy, surgery, and radiation, while having produced a measure of success with some cancers, have their limitations and can generate adverse side effects for patients.

The research efforts of these Young Investigators, pursuing newly emerging strategies within the cancer gene therapy field, represent significant potential applications for all forms of cancer and an improved quality of life for those being treated for cancer.

1.Anti-Angiogenesis:
Andrew Davidoff, M.D.
St. Jude Children's Research H
'"/>

Contact: Margaret Cianci
info@acgtfoundation.org
203-358-8000
Alliance for Cancer Gene Therapy
3-Mar-2003


Page: 1 2 3 4

Related biology news :

1. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
2. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
3. AACR and The V Foundation form Translational Cancer Research Alliance
4. Ecology lab aids Turtle Survival Alliance
5. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
6. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
7. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
8. Cancer gene MYC emerging as key research target
9. Cancer patient, heal thyself
10. USC researcher named General Motors Cancer Research Scholar
11. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/8/2019)... ... May 08, 2019 , ... FISO Technologies proudly ... microns and a lead-in fiber of 100 microns. With dimensions smaller than any ... itself as the world leader in the development of fiber optic sensors & ...
(Date:5/7/2019)... ... May 07, 2019 , ... AMGtime will be ... Entertainment Center from May 15- 17. At booth #226, AMGtime will be showcasing ... software, biometric hardware, mobile apps, specialized industry solutions, advanced add-on modules, seamless integrations, ...
(Date:5/2/2019)... ... April 30, 2019 , ... Global molecular ... today that Holotype HLA and other Omixon products will be featured in 12 ... (EFI) in Lisbon, Portugal. Among the major scientific events, Omixon’s Lunch ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... SANTA BARBARA, Calif. (PRWEB) , ... April 09, ... ... global professional services firm focused on increasing the capacity of life sciences organizations ... to its Cloud Assurance platform in the past 12 months. , ...
(Date:4/9/2019)... ... April 09, 2019 , ... The American Society ... of the Society's leadership team, including a new addition to the presidential line of ... their peers to join the Society's leadership team for a three-year term (2019-2021). , ...
(Date:4/8/2019)... ... , ... US Capital Global Securities , an affiliate of US Capital ... privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has a pipeline of drugs ... dysfunction disorder and is ready to begin phase 2b trials. In phase 2a trials, ...
(Date:4/4/2019)... , ... April 02, 2019 , ... ... solutions, announced it would be releasing it’s latest field-ready solution for performing PCR, ... Biomeme’s next-gen thermocycler Franklin™ pays homage to Rosland Franklin, an English chemist and ...
Breaking Biology Technology:
Cached News: